Pevonedistat
- Generic Name
- Pevonedistat
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C21H25N5O4S
- CAS Number
- 905579-51-3
- Unique Ingredient Identifier
- S3AZD8D215
- Background
Pevonedistat has been used in trials studying the treatment of Lymphoma, Solid Tumors, Multiple Myeloma, Hodgkin Lymphoma, and Metastatic Melanoma, among others.
- Associated Conditions
- -
- Associated Therapies
- -
Pevonedistat and Decitabine in Treating Patients With High Risk Acute Myeloid Leukemia
Phase 1
Active, not recruiting
- Conditions
- Acute Myeloid LeukemiaRefractory Acute Myeloid LeukemiaRecurrent Acute Myeloid LeukemiaSecondary Acute Myeloid LeukemiaTherapy-Related Acute Myeloid LeukemiaUntreated Adult Acute Myeloid Leukemia
- Interventions
- First Posted Date
- 2017-01-04
- Last Posted Date
- 2025-01-03
- Lead Sponsor
- City of Hope Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT03009240
- Locations
- 🇺🇸
City of Hope Medical Center, Duarte, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath